Skip to main content
SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD logo

SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000078 ISIN · CNE000000X95 LEI · 300300J4GCOV7CYQTB51 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,616 across all filing types
Latest filing 2024-04-24 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000078

About SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD

https://www.neptunusbio.com

Shenzhen Neptunus Bioengineering Co., Ltd. is a comprehensive healthcare enterprise focused on the research, development, manufacturing, and distribution of pharmaceutical products. The company operates across the entire industry value chain, including the production of chemical drugs, biological preparations, and traditional Chinese medicines. Its portfolio extends to medical devices and health supplements. A significant component of its operations involves a large-scale pharmaceutical distribution network and a nationwide retail pharmacy chain. The company emphasizes innovation in biotechnology and maintains modern production facilities to support its diverse product lines. By integrating R&D with a robust logistics and retail infrastructure, it provides a wide range of healthcare solutions to medical institutions and consumers.

Recent filings

Filing Released Lang Actions
第九届董事局第十四次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of the resolutions passed at the 14th meeting of the 9th Board of Directors of Shenzhen Haiwang Bioengineering Co., Ltd. It includes details about the meeting date, attendance, voting results, and references to related announcements published elsewhere. The content focuses on board decisions and meeting procedures rather than financial results or detailed reports. The document length is short (686 characters) and it is clearly a board meeting resolution announcement, which fits the category of Board/Management Information (MANG).
2024-04-24 Chinese
北京德恒（深圳）律师事务所关于深圳市海王生物股份有限公司2024年第二次临时股东大会的法律意见
Regulatory Filings Classification · 95% confidence The document is a legal opinion issued by a law firm regarding the convening, procedures, attendance, voting, and results of the 2024 second extraordinary general meeting of shareholders of Shenzhen Haiwang Bioengineering Co., Ltd. It details the legality and compliance of the meeting process and voting results. The document does not contain financial statements or financial performance data, nor is it a report of the meeting itself or a notice of voting results. Instead, it is a legal opinion on the meeting's procedural compliance. This type of document is best classified under Regulatory Filings (RNS) as it is a legal compliance document related to a shareholder meeting but not the meeting materials, voting results announcement, or management information.
2024-04-24 Chinese
2024年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement of the resolutions passed at the 2024 second extraordinary general meeting of shareholders of Shenzhen Haier Bioengineering Co., Ltd. It includes details about the meeting date, voting methods, attendance, voting results on specific proposals, and legal opinions confirming the validity of the meeting and resolutions. The content focuses on the voting results and meeting procedures rather than the full report or detailed financial data. The document length is relatively short (2389 characters), and it serves as an official announcement of voting results rather than a full report or presentation. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-04-23 Chinese
关于为控股子公司提供担保实施情况的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shenzhen Haiwang Bioengineering Co., Ltd. regarding the provision of guarantees for its subsidiaries. It details specific guarantee contracts, amounts, and terms, as well as cumulative guarantee balances. The document is relatively short (2100 characters) and focuses on disclosing guarantee activities rather than presenting financial statements or audit results. It does not contain financial performance data, audit opinions, or management discussions. It is a regulatory announcement about guarantee activities, which fits best under the category of Regulatory Filings (RNS) as it does not match other specific categories like Annual Report, Audit Report, or Capital/Financing Update. Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-04-19 Chinese
关于为控股子公司提供担保实施情况的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement from Shenzhen Haiwang Bioengineering Co., Ltd. regarding the implementation of guarantees provided to its controlling subsidiaries. It includes specific information about guarantee contracts, amounts, counterparties, and terms. The document is not a financial report, earnings release, or management discussion. It is a regulatory announcement about guarantees and related contractual details, which is typical for regulatory filings that do not fit into other specific categories. The document length is over 11,000 characters and contains no financial statements or audit opinions. Therefore, it fits best under Regulatory Filings (RNS).
2024-04-12 Chinese
关于股东部分股份解押及质押的公告
Major Shareholding Notification Classification · 100% confidence The document is a public announcement by Shenzhen Haier Bioengineering Co., Ltd. regarding the partial release and new pledging of shares by its controlling shareholder, Shenzhen Haier Group Co., Ltd. It details the number of shares pledged and released, the pledge purposes, and the shareholder's financial status. The content focuses on share pledge and release activities, including tables of share quantities and pledge ratios. There is no financial statement, earnings data, or management discussion. The document is not a report but an announcement about share pledging activities by a major shareholder. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership or share pledging by major shareholders.
2024-04-11 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.